MMJ International Holdings Rejects "Anti-Marijuana" Label, Defends Science Based Standards for Cannabinoid Medicines
MMJ International Holdings, Inc. ("MMJ") today responded to recent media coverage surrounding the challenge to the Centers for Medicare & Medicaid Services' (CMS) Substance Access Beneficiary Engagement Incentive (BEI) program, arguing that the ongoing portrayal of the litigation as a "pro-marijuana versus anti-marijuana" battle fundamentally misunderstands the issues at stake. According to MMJ, the case has never been about marijuana. It has...
Read more









